• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, INC VITEK® 2 AST-GP67 TEST KIT; VITEK® 2 AST-GP67 TEST CARD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, INC VITEK® 2 AST-GP67 TEST KIT; VITEK® 2 AST-GP67 TEST CARD Back to Search Results
Catalog Number 22226
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
A customer from the united states reported to biomérieux false negative cefoxitin screen results for two (2) samples from one patient (tracheal aspiration and blood culture) in association with the vitek® 2 ast-gp67 test kit.For the first sample (tracheal aspirate), two staphylococcus isolates were set up but not repeated on the vitek®.The second sample (blood culture), with two isolates set up, was repeated several times on the vitek® with the same results.The customer also tested the four isolates on an alternate system (phoenix) in which the 2 blood cultures and 1 trach aspirate isolate were (b)(6), and the other trach isolate was (b)(6).The staphylococcus aureus isolates were confirmed using filmarray® and the results were (b)(6).Other molecular testing confirmed the isolates to be pbp2a positive and (b)(6).The results from the vitek® 2 or alternate system were not reported to a physician, as it is customer procedure to confirm with molecular testing.The (b)(6) result was reported to the physician.There is no indication or report from the hospital or treating physician to biomérieux that the discrepant result led to any adverse event related to the patient's state of health.The test reports and isolates were requested from the customer.
 
Manufacturer Narrative
A customer from the united states reported to biomérieux false negative cefoxitin screen results for two (2) samples from one patient (tracheal aspiration and blood culture) in association with the vitek® 2 ast-gp67 test kit.An internal biomérieux investigation was performed.Four (4) submitted isolates were subcultured, identifications confirmed, and vitek® 2 ast-gp67 testing included cards from the customer's lot and a random lot, in duplicate.Additional testing included agar dilution (ad) reference method for ox101n formulation, cefoxitin disc diffusion as the reference method for oxfs and pbp2a.The 911296 (w44346-1r): all four (4) vitek® 2 ast-gp67 cards tested resulted in mics = 0.5 and negative oxfs.Ad mic = 1.0 so vitek® 2 cards were in essential agreement with the reference method for oxacillin.Cefoxitin disc (18 mm) was resistant and pbp2a was positive, confirming the false negative oxfs.The 911297 (w44346-2 r): all four (4) vitek® 2 ast-gp67 cards tested resulted in mics
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® 2 AST-GP67 TEST KIT
Type of Device
VITEK® 2 AST-GP67 TEST CARD
Manufacturer (Section D)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer (Section G)
BIOMERIEUX, INC
595 anglum road
st. louis MO 63042
Manufacturer Contact
ellen weltmer
595 anglum road
st. louis, MO 63042
3147317301
MDR Report Key6349544
MDR Text Key68224543
Report Number1950204-2017-00059
Device Sequence Number1
Product Code LQL
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K952095
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 04/18/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/04/2018
Device Catalogue Number22226
Device Lot Number1320159103
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/25/2017
Initial Date FDA Received02/22/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/18/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/04/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-